Clinical Trial Details


Back to Clinical Trials Database

A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to Imatinib mesylate.

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 20-May-2009
Date Step1 close: 11-Mar-2011
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 280 - All Groups: 350
Treatment Imatinib
Study Staff
Type of cancer
Participating groups EORTC Soft Tissue and Bone Sarcoma Group
Australasian Gastro-Intestinal Trials Group
Italian Sarcoma Group
French Sarcoma Group
Grupo Espanol de Investigacion en sarcomas
Protocol summary
NCT number NCT00956072
EudraCT 2007-002257-23